Regen BioPharma Inc (RGBP)

[SidVicious]

There is still some serious confusion. The initial pre-clinical work isn't where the major costs are and is irrelevant to BP. It's the actual clinical trials where millions, tens of millions if not billions of dollars can be spent to get a drug to market. Why do you think Koos' failed business plan, and now vaporware Onph business plan, was to try and sell their therapies after P1 trials?

Recall, Koos was unable to find ANYONE interested in paying for P1 trial for Hemaxellerate. Regen didn't have the money. Koos couldn't raise it because he's a deadbeat nobody in the biotech field. He has ZERO connections. All of the so called advisors he has were of no help in finding any funding.

The story remains the same no matter how much spin is posted on here.

10 different therapies are now worth .0016 of a cent each. How special is that?

Did you also know that Koos is persona non grata in San Diego's lab tech world? Who wants to do business with a guy that you know won't pay you? Not a good look at all. It's why Koos' is letting ONPH try its hand at a failed business model.

And why did Koos leave Regen in the first place? He took the time to put up his new sickly picture and phone number but couldn't take one minute to remove those on the fake advisory board that truly had very minimal interaction with the company? PLUUUUUEEEAAASE!

SMOKE AND MIRRORS FROM AN INCOMPETENT CEO.

Even more sad is that there is no major Pharma with any interest at all with what RGBP has. Even Lilly, after allowing Regen to utilize its molecule library, had no interest in what Regen had found.

Ignore that are your own peril.

U N D E N I A B L E - F A C T!